Jaideep Dudani

Jaideep Dudani

Private Equity Investor at Monograph Capital Advisors (UK) LLP

Finance
Health Technology
Consumer Services

Profile

Jaideep Dudani is a Portfolio Principal at Monograph and leads Portfolio Development at Monograph’s portfolio company, Hi-Bio.
He was most recently at Relay Therapeutics, a precision medicine company focused on oncology and rare genetic diseases, where he played a cross-functional role in R&D and strategy and business development.
Before that, Jaideep was the first associate at Vida Ventures, and was involved in several of Vida’s investments, including Allogene Therapeutics (which held its initial public offering on the NASDAQ Global Select Market in 2018), Asklepios BioPharmaceutical (which was acquired by Bayer AG in 2020), Oyster Point Pharma (which held its initial public offering on the NASDAQ Global Select Market in 2019), and Pionyr Immunotherapeutics (which was acquired by Gilead Sciences, Inc. in 2020).
He completed his PhD at MIT in Biological Engineering, and holds a BS in Bioengineering from UCLA.

Jaideep Dudani active positions

CompaniesPositionStart
Private Equity Investor 30/06/2021
All active positions of Jaideep Dudani

Former positions of Jaideep Dudani

CompaniesPositionEnd
RELAY THERAPEUTICS, INC. Corporate Officer/Principal 29/06/2021
Consultant / Advisor 30/03/2018
See the detail of Jaideep Dudani's experience

Training of Jaideep Dudani

Massachusetts Institute of Technology Doctorate Degree
University of California, Los Angeles Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jaideep Dudani's experience

Connections

99

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
RELAY THERAPEUTICS, INC.

Health Technology

Private companies2

Finance

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Jaideep Dudani